Design of a folding inhibitor of the HIV-1 protease

被引:2
|
作者
Tiana, G
Broglia, RA
Sutto, L
Provasi, D
机构
[1] Univ Milan, Dipartimento Fis, I-20133 Milan, Italy
[2] Ist Nazl Fis Nucl, I-20133 Milan, Italy
[3] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark
关键词
HIV-1; protease; Monte Carlo simulations; local elementary structures; HIV-PR monomer;
D O I
10.1080/089270500262721
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
A novel way to inhibit HIV-1 protease by destabilizing its native state is discussed. A simplified protein model is used together with Monte Carlo simulations, to assess the destabilizing effect of peptides displaying the same sequence as specific fragments of the protein which are essential for its stability. Model calculations also show that it is unlikely that the protein can escape the inhibitory peptide by point mutations.
引用
收藏
页码:765 / 771
页数:7
相关论文
共 50 条
  • [21] Adaptability and flexibility of HIV-1 protease
    Kumar, M
    Hosur, MV
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 2003, 270 (06): : 1231 - 1239
  • [22] Structural analysis of inhibitor binding to HIV-1 protease: identification of a common binding motif
    Covell, DG
    Jernigan, RL
    Wallqvist, A
    THEOCHEM-JOURNAL OF MOLECULAR STRUCTURE, 1998, 423 (1-2): : 93 - 100
  • [23] Acquisition of multi-PI (protease inhibitor) resistance in HIV-1 in vivo and in vitro
    Yusa, K
    Harada, S
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (32) : 4055 - 4064
  • [24] Single point mutation induced alterations in the equilibrium structural transitions on the folding landscape of HIV-1 protease
    Rout, Manoj Kumar
    Reddy, Jithender G.
    Phillips, Margaret
    Hosur, Ramakrishna V.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2013, 31 (07): : 684 - 693
  • [25] Drug design: New inhibitors for HIV-1 protease based on Nelfinavir as lead
    Perez, M. A. S.
    Fernandes, P. A.
    Ramos, M. J.
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2007, 26 (03): : 634 - 642
  • [26] FMO-guided design of darunavir analogs as HIV-1 protease inhibitors
    Chuntakaruk, Hathaichanok
    Hengphasatporn, Kowit
    Shigeta, Yasuteru
    Aonbangkhen, Chanat
    Lee, Vannajan Sanghiran
    Khotavivattana, Tanatorn
    Rungrotmongkol, Thanyada
    Hannongbua, Supot
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [27] Off-Target-Based Design of Selective HIV-1 PROTEASE Inhibitors
    Monica, Gabriele La
    Lauria, Antonino
    Bono, Alessia
    Martorana, Annamaria
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (11)
  • [28] Inhibitory effects of Sudanese plant extracts on HIV-1 replication and HIV-1 protease
    Hussein, G
    Miyashiro, H
    Nakamura, N
    Hattori, M
    Kawahata, T
    Otake, T
    Kakiuchi, N
    Shimotohno, K
    PHYTOTHERAPY RESEARCH, 1999, 13 (01) : 31 - 36
  • [29] HIV-1 protease and HIV-1 integrase inhibitory substances from Eclipta prostrata
    Tewtrakul, Supinya
    Subhadhirasakul, Sanan
    Cheenpracha, Sarot
    Karalai, Chatchanok
    PHYTOTHERAPY RESEARCH, 2007, 21 (11) : 1092 - 1095
  • [30] Unexpected binding mode of a cyclic sulfamide HIV-1 protease inhibitor
    Backbro, K
    Lowgren, S
    Osterlund, K
    Atepo, J
    Unge, T
    Hulten, J
    Bonham, NM
    Schaal, W
    Karlen, A
    Hallberg, A
    JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (06) : 898 - 902